Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: A follow-up study

Fertility and Sterility

Volumn 100, Issue 3, 2013, Pages 831-838.e2

  Yarde, Felicia ^a   Voorhuis, Marlies ^a   Dólleman, Madeleine ^a   Knauff, Erik A H ^a   Eijkemans, Marinus J C ^a   Broekmans, Frank J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

antim llerian hormone; elevated basal FSH; live birth; prediction; Subfertility

Indexed keywords

FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; AGE; CLIMACTERIUM; COHORT ANALYSIS; CONFERENCE PAPER; FEMALE; FEMALE SUBFERTILITY; FETUS WASTAGE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MENOPAUSE; MENSTRUAL CYCLE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVARIAN RESERVE; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; SCREENING;

EID: 84883449375     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.05.009     Document Type: Conference Paper

References (57)

1. E.R. Te Velde, and P.L. Pearson The variability of female reproductive ageing Hum Reprod Update 8 2002 141 154
2. F.J. Broekmans, M.R. Soules, and B.C. Fauser Ovarian aging: mechanisms and clinical consequences Endocrinol Rev 30 2009 465 493
3. M.J. Faddy, R.G. Gosden, A. Gougeon, S.J. Richardson, and J.F. Nelson Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause Hum Reprod 7 1992 1342 1346
4. K.R. Hansen, N.S. Knowlton, A.C. Thyer, J.S. Charleston, M.R. Soules, and N.A. Klein A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause Hum Reprod 23 2008 699 708
5. W.H. Wallace, and T.W. Kelsey Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography Hum Reprod 19 2004 1612 1617
6. S.D. Harlow, M. Gass, J.E. Hall, R. Lobo, P. Maki, and R.W. Rebar Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging J Clin Endocrinol Metab 97 2012 1159 1168
7. B.M. Sherman, and S.G. Korenman Hormonal characteristics of the human menstrual cycle throughout reproductive life J Clin Invest 55 1975 699 706
8. R.T. Scott Jr., and G.E. Hofmann Prognostic assessment of ovarian reserve Fertil Steril 63 1995 1 11
9. C.C. Tay, A.F. Glasier, and A.S. McNeilly Effect of antagonists of dopamine and opiates on the basal and GnRH-induced secretion of luteinizing hormone, follicle stimulating hormone and prolactin during lactational amenorrhoea in breastfeeding women Hum Reprod 8 1993 532 539
10. H. Jernstrom, M. Knutsson, and H. Olsson Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use Contraception 52 1995 51 56
11. Lambalk CB, Boomsma DI, de Boer L, de Koning CH, Schoute E, Popp-Snijders C, et al. Increased levels and pulsatility of follicle-stimulating hormone in mothers of hereditary dizygotic twins. J Clin Endocrinol Metab 1998;83:481-6.
12. C.H. De Koning, T. Benjamins, P. Harms, R. Homburg, J.M. van Montfrans, and J. Gromoll The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles Hum Reprod 21 2006 443 446
13. M.M. Perez, J. Gromoll, H.M. Behre, C. Gassner, E. Nieschlag, and M. Simoni Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype J Clin Endocrinol Metab 85 2000 3365 3369
14. S. Sudo, M. Kudo, S. Wada, O. Sato, A.J. Hsueh, and S. Fujimoto Genetic and functional analyses of polymorphisms in the human FSH receptor gene Mol Hum Reprod 8 2002 893 899
15. E.A. Knauff, M.J. Eijkemans, C.B. Lambalk, M.J. ten Kate-Booij, A. Hoek, and C.C. Beerendonk Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure J Clin Endocrinol Metab 94 2009 786 792
16. S.L. Broer, B. Mol, M. Dolleman, B.C. Fauser, and F.J. Broekmans The role of anti-Mullerian hormone assessment in assisted reproductive technology outcome Curr Opin Obstet Gynecol 22 2010 193 201
17. T. Ebner, M. Sommergruber, M. Moser, O. Shebl, E. Schreier-Lechner, and G. Tews Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles Hum Reprod 21 2006 2022 2026
18. A. Hazout, P. Bouchard, D.B. Seifer, P. Aussage, A.M. Junca, and P. Cohen-Bacrie Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol Fertil Steril 82 2004 1323 1329
19. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy Hum Reprod 22 2007 2414 2421
20. R.M. Riggs, E.H. Duran, M.W. Baker, T.D. Kimble, E. Hobeika, and L. Yin Assessment of ovarian reserve with anti-Mullerian hormone: a comparison of the predictive value of anti-Mullerian hormone, follicle-stimulating hormone, inhibin B, and age Am J Obstet Gynecol 199 2008 202 208
21. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. te Velde, and F.J. Broekmans Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J Clin Endocrinol Metab 91 2006 4057 4063
22. Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 2008;90:737-43.
23. A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe Serum anti-Mullerian hormone throughout the human menstrual cycle Hum Reprod 21 2006 3103 3107
24. I. Van Rooij, F.J. Broekmans, G.J. Scheffer, C.W. Looman, J.D. Habbema, and F.H. de Jong Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study Fertil Steril 83 2005 979 987
25. A. De Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimullerian hormone serum levels: a putative marker for ovarian aging Fertil Steril 77 2002 357 362
26. A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, and N.S. Macklon Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 24 2009 2264 2275
27. K.P. Tremellen, M. Kolo, A. Gilmore, and D.N. Lekamge Anti-mullerian hormone as a marker of ovarian reserve Aust N Z J Obstet Gynaecol 45 2005 20 24
28. E. Buyuk, D.B. Seifer, J. Younger, R.V. Grazi, and H. Lieman Random anti-Mullerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels Fertil Steril 95 2011 2369 2372
29. N. Gleicher, A. Weghofer, and D.H. Barad Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve Fertil Steril 94 2010 2824 2827
30. M.L. Haadsma, A. Bukman, H. Groen, E.M. Roeloffzen, E.R. Groenewoud, and M.J. Heineman The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population Hum Reprod 22 2007 1925 1931
31. Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril 2010;94:1044-51.
32. J.W. Van der Steeg, P. Steures, M.J. Eijkemans, J.D. Habbema, P.G. Hompes, and F.J. Broekmans Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples Hum Reprod 22 2007 536 542
33. J.M. Van Montfrans, A. Hoek, M.H. van Hooff, C.H. de Koning, N. Tonch, and C.B. Lambalk Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population Fertil Steril 74 2000 97 103
34. I. Van Rooij, L.F. Bancsi, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. te Velde Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization Fertil Steril 79 2003 482 488
35. Van Rooij I, de Jong E, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril 2004;81:1478-85.
36. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Hum Reprod Update 12 2006 685 718
37. L.F. Bancsi, F.J. Broekmans, B.W. Mol, J.D. Habbema, and E.R. te Velde Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis Fertil Steril 79 2003 1091 1100
38. D.J. Hendriks, E.R. te Velde, C.W. Looman, L.F. Bancsi, and F.J. Broekmans Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool Reprod Biomed Online 17 2008 727 736
39. M.R. Sowers, A.D. Eyvazzadeh, D. McConnell, M. Yosef, M.L. Jannausch, and D. Zhang Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition J Clin Endocrinol Metab 93 2008 3478 3483
40. Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update 2013;19:26-36.
41. A. Weghofer, W. Dietrich, D.H. Barad, and N. Gleicher Live birth chances in women with extremely low-serum anti-Mullerian hormone levels Hum Reprod 26 2011 1905 1909
42. Fraisse T, Ibecheole V, Streuli I, Bischof P, de Ziegler D. Undetectable serum anti-Mullerian hormone levels and occurrence of ongoing pregnancy. Fertil Steril 2008;89:723-11.
43. O. Rustamov, A. Smith, S.A. Roberts, A.P. Yates, C. Fitzgerald, and M. Krishnan Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability Hum Reprod 27 2012 3085 3091
44. M. Dólleman, W.M.M. Verschuren, M.J.C. Eijkemans, M.E.T. Dollé, E.H.J.M. Jansen, and F.J.M. Broekmans Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study J Clin Endocrinol Metab 98 2013 2106 2115
45. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 714
46. T. Silberstein, D.T. MacLaughlin, I. Shai, J.R. Trimarchi, G. Lambert-Messerlian, and D.B. Seifer Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology Hum Reprod 21 2006 159 163
47. I. Van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, and F.H. de Jong Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
48. S.K. Sunkara, V. Rittenberg, N. Raine-Fenning, S. Bhattacharya, J. Zamora, and A. Coomarasamy Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Hum Reprod 26 2011 1768 1774
49. T. Timeva, T. Milachich, I. Antonova, T. Arabaji, A. Shterev, and H.A. Omar Correlation between number of retrieved oocytes and pregnancy rate after in vitro fertilization/intracytoplasmic sperm infection ScientificWorldJournal 6 2006 686 690
50. M.H. Van der Gaast, M.J. Eijkemans, J.B. van der Net, E.J. de Boer, C.W. Burger, and F.E. van Leeuwen Optimum number of oocytes for a successful first IVF treatment cycle Reprod Biomed Online 13 2006 476 480
51. M.C. Yih, S.D. Spandorfer, and Z. Rosenwaks Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Fertil Steril 83 2005 24 29
52. A. La Marca, S.M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, and L. Roli Anti-Mullerian hormone-based prediction model for a live birth in assisted reproduction Reprod Biomed Online 22 2011 341 349
53. J.R. Brown, H.C. Liu, K.F. Sewitch, Z. Rosenwaks, and A.S. Berkeley Variability of day 3 follicle-stimulating hormone levels in eumenorrheic women J Reprod Med 40 1995 620 624
54. T. Jain, N.A. Klein, D.M. Lee, P.M. Sluss, and M.R. Soules Endocrine assessment of relative reproductive age in normal eumenorrheic younger and older women across multiple cycles Am J Obstet Gynecol 189 2003 1080 1084
55. C.H. De Koning, J. McDonnell, A.P. Themmen, F.H. de Jong, R. Homburg, and C.B. Lambalk The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls Hum Reprod 23 2008 1416 1423
56. A. Kumar, B. Kalra, A. Patel, L. McDavid, and W.E. Roudebush Development of a second generation anti-Mullerian hormone (AMH) ELISA J Immunol Methods 362 2010 51 59
57. M.R. Soules, S. Sherman, E. Parrott, R. Rebar, N. Santoro, and W. Utian Stages of Reproductive Aging Workshop (STRAW) J Womens Health Gend Based Med 10 2001 843 848